Subscribe to this Blog
Elekta Word Cloud

VMAT

Clinicians cut VMAT planning times, aim to increase access to rapid radiotherapy for more patients

Intensity Modulated Radiation Therapy (IMRT) and Volumetric Modulated Arc Therapy (VMAT) delivery techniques have dramatically reduced treatment times for thousands of patients. An obstacle to offering this technique to more patients is the time it takes to create a VMAT plan. Physicians at St. James’s University Hospital – the first in the United Kingdom to use Monaco® VMAT clinically – have been able to significantly reduce VMAT planning times, increasing the potential to offer this advanced therapy to greater numbers of patients.

 

“Our referral rate for radiation therapy is expanding by over seven percent annually,” says St. James’s head of radiotherapy physics Vivian Cosgrove, Ph.D. “We see VMAT as a key way to manage that growth. If we can plan complex radiotherapy quickly and deliver treatment more efficiently with VMAT, then we can treat more patients and derive more benefit from our existing fleet of treatment machines.”

 

Elekta VMAT is an advanced radiation therapy technique that delivers treatment in one or more continuous high-speed arcs around the patient, enabling the radiation dose to precisely conform to a tumor by modulating the radiation beam’s intensity in multiple small volumes.

 

The key to rapidly developing Elekta VMAT plans lies in understanding the principles of efficiently producing traditional IMRT plans with step-and-shoot (i.e., non-dynamic) delivery. Medical physics staff at St. James’s have used Monaco since January 2011 to plan head-and-neck IMRT cases.

 

“Monaco has transformed our IMRT service,” Dr. Cosgrove notes. “After contouring, we can complete a complex head-and-neck plan in two to three hours. This is two to three times quicker than other planning systems we have used. Since we introduced Monaco clinically, we have been able to significantly increase the number of patients receiving intensity modulated treatment: over 260 patients in 2011 and a target to increase this further in 2012.”

 

That number includes many patients who have received VMAT planned with Monaco, which St. James’s clinicians began performing in August 2011 on one of its 12 Elekta digital accelerators.

 

VMAT delivery of head-and-neck cases takes 6.5 minutes, half the time of a seven-field step-and-shoot delivery, he says. Read more at: http://www.elekta.com/healthcare_international_press_release_20071328.php.

 

Intended for radiation oncologists, medical physicists, dosimetrists and nurses interested in VMAT and IGRT training, this one and a half day course is December 5-6 at Swedish Cancer Institute in Seattle, Washington.

 

The program includes topics such as defining target volumes; clinical implementation; billing issues; quality assurance; various tumor application: thoracic, head and neck, prostate, abdominal, and breast; hypofractionated stereotactic radiotherapy protocols; and patient education.

 

In addition to the didactic sessions, the course includes a demonstration in real time of CBCT technology. Each participant will receive a manual which will provide additional information for each member of your cancer care team and a CD of PowerPoint presentations.

 

Upon completion, participants will be able to address:

  • Target volumes for IGRT
  • Billing
  • Coding and reimbursement issues
  • Practical aspects of setting up an image-guided radiotherapy program
  • The role of IGRT in the treatment of various tumor types
  • Research results

 

To register and view the agenda, visit: http://www.elekta.com/events_detail.php?id=1093

Institution: University of Colorado Cancer Center, Denver, Colorado, US

Patient: 72 year old male

Diagnosis: Localized small cell carcinoma of the distal thoracic esophagus

Plan:  Stereotactic body radiation therapy (SBRT) using VMAT

 

Patient History and Diagnosis

This 72 year old male presented with a localized small cell carcinoma of the distal thoracic esophagus. He underwent a single cycle of cisplatin and esoposide followed by concurrent chemoradiation therapy, using 3D conformal radiotherapy to encompase the esophageal primary and regional lymph nodes. He received a total dose of 45 Gy in 25 fractions along with the second cycle of cisplatin and etoposide. He received 4 additional cycles of chemotherapy.

 

He remained well until restaging with PET-CT 8 months following completion of therapy showed a new FDG-avid hypodensity in the right lobe of the liver, segment 6. The lesion measured 2.0 x 1.7 cm and had a SUV of 6. A MRI of the brain was negative. The PET was negative in the region of the esophageal primary as were upper endoscopy and biopsy. The patient performance status was excellent and despite the usual aggressive course of extra-pulmonary small cell carcinoma, because his primary was controlled, we elected to be aggressive with this solitary liver metastasis.

 

Download the entire case study here: http://www.elekta.com/assets/new-proof/assets/Software/CS%20Stereotactic%20Body%20Radiation%20Therapy%20for%20Liver%20Cancer%20Using%20the%20Monaco%20Treatment%20Planning%20System%20and%20VMAT%20Delivery%20at%20University%20of%20Colorado%20Cancer%20Center%20Denver%20Colorado.pdf.

Radiation oncologists and medical physicists expect their treatment systems to do a lot these days and VMAT is a perfect example. In a single technique, radiation therapy moved from static to fully dynamic – with the gantry, MLC and collimator all moving simultaneously, and on-the-fly gantry speed and dose rate modulation throughout the VMAT arc. VMAT ushered in the kind of complexity that demands a robust control system. Clinicians at Mary Bird Perkins Cancer Center (MBPCC, Baton Rouge, La., USA) recognized the challenges and opportunities that sophisticated methods present and decided to upgrade their Elekta Infinity™ linac with the Integrity™ control system. Read the rest of this entry »
In just four years, Clinique Claude Bernard’s Private Radiotherapy Center (PRCM) will have doubled the number of patients receiving radiation therapy treatments per year – from 1,100 to a predicted 2,200 patients by the end of this year. This achievement was enabled by equipping first one, then all three of its Elekta Synergy® treatment systems with Elekta VMAT. On April 28, a patient with breast cancer became PRCM’s 2,500th to receive VMAT since the clinic began using the technique in 2009. Read the rest of this entry »
Elekta and ScandiDos AB have entered into a non-exclusive global agreement to distribute ScandiDos’s Delta4PT quality assurance (QA) tool. Delta4PT can be used with Intensity Modulated Radiation Therapy (IMRT) and Volumetric Modulated Arc Therapy (VMAT) techniques to provide complete pre-treatment QA that ensures that the dose prescribed in treatment plans is delivered accurately and safely to patients. Read the rest of this entry »
India’s population of 1.15 billion significantly dwarfs the number of radiotherapy systems available to serve its residents. Among 289 radiation therapy centers countrywide are approximately 250 linear accelerators, 270 telecobalt machines and 170 HDR brachytherapy systems. To match a developed nation’s ratio of inhabitants to linear accelerators alone, India would need about 10 times as many treatment systems, says Tejinder Kataria, M.D., Chairperson of the Radiation Oncology department at Medanta Cancer Institute, part of Medanta – The Medicity (Gurgaon, Haryana, India). Read the rest of this entry »
The prospect of dramatically increasing radiation therapy treatment speed using dynamic, arc-based radiation therapy is capturing the imagination of Indian clinicians, if Dr. Vivek Mehta’s recent experience is any indication. Dr. Mehta, a radiation oncologist at Swedish Cancer Institute (Seattle, Wash., USA) gave three lectures on Elekta VMAT at the 32nd National Annual Conference of the Association of Radiation Oncologists of India Conference (AROICON) Nov. 25-28, 2010, in Patna, India, which drew capacity attendance and provoked vibrant interaction and discussion among participants. Read the rest of this entry »
Elekta has a long history of collaboration with clinical partners on product development and new innovations. We have worked with our customers to create an extensive range of clinically focused material offering valuable information about product use, implementation and background to product development. Read the rest of this entry »
In September, a 75-year-old Italian man with locally advanced, non-small cell lung cancer became the first patient at San Giovanni-Battista Hospital to benefit from Elekta VMAT, an advanced radiation therapy technique that delivers treatment in one or more high-speed arcs around the patient. While a conventional IMRT technique would have taken up to 20 minutes for the patient’s radiation delivery, Elekta VMAT completed its single therapy arc in only seven minutes. Over the patient’s 24 separate treatment sessions, Elekta VMAT spared him over five hours of extra time on the therapy table. Read the rest of this entry »